Richard B. Schwab
UCSF Helen Diller Family Comprehensive Cancer Center(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Genetic factors in colorectal cancer, Advanced Breast Cancer Therapies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer(2020)685 cited
- → Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer(2016)546 cited
- → Adaptive Randomization of Neratinib in Early Breast Cancer(2016)456 cited
- → Reproductive risk factors and breast cancer subtypes: a review of the literature(2014)377 cited
- → Exploring the landscape of focal amplifications in cancer using AmpliconArchitect(2019)349 cited
- → Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial(2021)308 cited
- → Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy(2020)288 cited
- → HER2 aberrations in cancer: Implications for therapy(2014)215 cited
- → Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer(2020)213 cited
- → Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience(2014)194 cited